Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2017

Open Access 01-12-2017 | Study protocol

Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial

Authors: Richard A. Van Dorn, Sarah L. Desmarais, Candalyn B. Rade, Elizabeth N. Burris, Gary S. Cuddeback, Kiersten L. Johnson, Stephen J. Tueller, Megan L. Comfort, Kim T. Mueser

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

Adults with co-occurring mental and substance use disorders (CODs) are overrepresented in jails. In-custody barriers to treatment, including a lack of evidence-based treatment options and the often short periods of incarceration, and limited communication between jails and community-based treatment agencies that can hinder immediate enrollment into community care once released have contributed to a cycle of limited treatment engagement, unaddressed criminogenic risks, and (re)arrest among this vulnerable and high-risk population. This paper describes a study that will develop research and communication protocols and adapt two evidence-based treatments, dual-diagnosis motivational interviewing (DDMI) and integrated group therapy (IGT), for delivery to adults with CODs across a jail-to-community treatment continuum.

Methods/design

Adaptations to DDMI and IGT were guided by the Risk-Need-Responsivity model and the National Institute of Corrections’ implementation competencies; the development of the implementation framework and communication protocols were guided by the Evidence-Based Interagency Implementation Model for community corrections and the Inter-organizational Relationship model, respectively. Implementation and evaluation of the protocols and adapted interventions will occur via an open trial and a pilot randomized trial. The clinical intervention consists of two in-jail DDMI sessions and 12 in-community IGT sessions. Twelve adults with CODs and four clinicians will participate in the open trial to evaluate the acceptability and feasibility of, and fidelity to, the interventions and research and communication protocols. The pilot controlled trial will be conducted with 60 inmates who will be randomized to either DDMI-IGT or treatment as usual. A baseline assessment will be conducted in jail, and four community-based assessments will be conducted during a 6-month follow-up period. Implementation, clinical, public health, and treatment preference outcomes will be evaluated.

Discussion

Findings have the potential to improve both jail- and community-based treatment services for adults with CODs as well as inform methods for conducting rigorous pilot implementation and evaluation research in correctional settings and as inmates re-enter the community. Findings will contribute to a growing area of work focused on interrupting the cycle of limited treatment engagement, unaddressed criminogenic risks, and (re)arrest among adults with CODs.

Trial registration

ClinicalTrials.gov, NCT02214667. Registered on 10 August 2014.
Appendix
Available only for authorised users
Literature
1.
Steadman HJ, et al. Prevalence of serious mental illness among jail inmates. Psychiatric Services. 2009;60(6):761–5.CrossRefPubMed
2.
Drake RE, Brunette MF. Complications of severe mental illness related to alcohol and drug use disorders. In: Galanter M, editor. Recent developments in alcoholism, vol. 14. New York: Plenum Publishing; 1998. p. 285–99.CrossRef
3.
4.
Desmarais SL, et al. Accuracy of self-report, biological tests, collateral reports and clinician ratings in identifying substance use disorders among adults with schizophrenia. Psychology Addictive Behav. 2013;27(3):774-87.
5.
Dickey B, Azeni H. Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care. Am J Public Health. 1996;86(7):973–7.CrossRefPubMedPubMedCentral
6.
Essock SM, et al. Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatric Services. 2006;57(2):185–95.CrossRefPubMed
7.
Friedmann PD, et al. Collaborative behavioral management among parolees: drug use, crime and re‐arrest in the Step'n Out randomized trial. Addiction. 2012;107(6):1099–108.CrossRefPubMedPubMedCentral
8.
Van Dorn R, Volavka J, Johnson N. Mental disorder and violence: is there a relationship beyond substance use? Soc Psychiatry Psychiatric Epidemiology. 2012;47(3):487–503.CrossRef
9.
Van Dorn RA, et al. Effects of outpatient treatment on risk of arrest of adults with serious mental illness and associated costs. Psychiatric Services. 2013;64(9):856–62.CrossRefPubMed
10.
Drake RE, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services. 2001;52(4):469–76.CrossRefPubMed
11.
Ford L, Snowden LR, Walser EJ. Outpatient mental health and the dual-diagnosis patient: utilization of services and community adjustment. Evaluation Progr Plan. 1991;14(4):291–8.CrossRef
12.
Chandler RK, et al. Challenges in implementing evidence‐based treatment practices for co‐occurring disorders in the criminal justice system. Behav Sci Law. 2004;22(4):431–48.CrossRefPubMed
13.
Drake RE, et al. Psychosocial aspects of substance abuse by clients with severe mental illness. J Nerv Mental Dis. 2002;190(2):100–6.CrossRef
14.
Drake RE, et al. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bull. 1998;24(4):589–608.CrossRef
15.
Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophrenia Bull. 2000;26(1):105–18.CrossRef
16.
Mueser KT, et al. Illness management and recovery: a review of the research. Psychiatric Services. 2002;53(10):1272–84.CrossRefPubMed
17.
Cohen F, Dvoskin J. Inmates with mental disorders: a guide to law and practice. Mental Physical Disability Law Report. 1992;16(3):339–46.
18.
Osher F, Steadman HJ, Barr H. A best practice approach to community reentry from jails for inmates with co-occurring disorders: the APIC model. Crime and Delinquency. 2003;49(1):79–96.
19.
Munetz MR, Griffin PA. Use of the sequential intercept model as an approach to decriminalization of people with serious mental illness. Psychiatric Services. 2006;57(4):544–9.CrossRefPubMed
20.
21.
Adair CE, et al. History and measurement of continuity of care in mental health services and evidence of its role in outcomes. Psychiatric Services. 2003;54(10):1351–6.CrossRefPubMed
22.
Crawford MJ, et al. Providing continuity of care for people with severe mental illness. Soc Psychiatry Psychiatric Epidemiology. 2004;39(4):265–72.CrossRef
23.
Kuno E, et al. A service system planning model for individuals with serious mental illness. Mental Health Services Res. 2005;7(3):135–44.CrossRef
24.
Swartz MS, Swanson JW. Involuntary outpatient commitment, community treatment orders, and assisted outpatient treatment: what's in the data? Canad J Psychiatry. 2004;49(9):585–91.CrossRef
25.
Martino S, et al. A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction. 2006;101(10):1479–92.CrossRefPubMed
26.
Martino S, et al. Dual diagnosis motivational interviewing: a modification of motivational interviewing for substance-abusing patients with psychotic disorders. J Subst Abuse Treat. 2002;23(4):297–308.CrossRefPubMedPubMedCentral
27.
Martino S, et al. Motivational interviewing with psychiatrically ill substance abusing patients. Am J Addictions. 2000;9(1):88–91.CrossRef
28.
Weiss R, et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry. 2007;164(1):100–7.CrossRefPubMed
29.
Weiss RD, et al. Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study. J Clinical Psychiatry. 2000;61(5):361–7.CrossRef
30.
Weiss RD, Connery HS. Integrated group therapy for bipolar disorder and substance abuse. New York: Guilford Press; 2011.
31.
Weiss RD, et al. A “community-friendly” version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Dependence. 2009;104(3):212–9.CrossRefPubMedPubMedCentral
32.
Ziedonis DM, et al. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatric Practice. 2005;11(5):315-39.
33.
National Institute on Drug Abuse. Comorbidity: addiction and other mental illnesses. Washington DC: Department of Health and Human Services; 2008.
34.
Monti PM. Treating alcohol dependence: a coping skills training guide. New York: Guilford Press; 2002.
35.
Beck AT, et al. Cognitive therapy of substance abuse. New York: Guilford Press; 2001.
36.
Butler AC, et al. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clinical Psychology Rev. 2006;26(1):17–31.CrossRef
37.
Landenberger NA, Lipsey MW. The positive effects of cognitive–behavioral programs for offenders: a meta-analysis of factors associated with effective treatment. J Experimental Criminology. 2005;1(4):451–76.CrossRef
38.
39.
Bonta J, Andrews DA. Risk-need-responsivity model for offender assessment and rehabilitation. Ottawa: Public Safety Canada; 2007.
40.
Taxman FS, Belenko SR. Implementing evidence-based practices in community corrections and addiction treatment. New York: Springer; 2012.CrossRef
41.
Delaney FG. Muddling through the middle ground: theoretical concerns in intersectoral collaboration and health promotion. Health Promotion Internat. 1994;9(3):217–25.CrossRef
42.
Beatrice DF. Inter-agency coordination: a practitioner's guide to a strategy for effective social policy. Administration Soc Work. 1991;14(4):45–59.CrossRef
43.
Fottler MD, et al. Multi-institutional arrangements in health care: review, analysis, and a proposal for future research. Academy of Manag Rev. 1982;7(1):67–79.
44.
Fox J, Merwin E, Blank M. De facto mental health services in the rural south. J Health Care for the Poor and Underserved. 1995;6(4):434–68.CrossRef
45.
Steadman HJ, et al. Validation of the Brief Jail Mental Health Screen. Psychiatric Services. 2005;56(7):816–22.CrossRefPubMed
46.
Atkisson C, Greenfield T, Maruish M. The Client Satisfaction Questionnaire-8 and the Service Satisfaction Questionnaire-30, psychological testing: treatment planning and outcome assessment. Hillsdale: Lawrence Erlbaum; 1994.
47.
Nguyen TD, Attkisson CC, Stegner BL. Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Evaluation Progr Plan. 1983;6(3-4):299–313.CrossRef
48.
Hasson-Ohayon I, Roe D, Kravetz S. A qualitative approach to the evaluation of psychosocial interventions for persons with severe mental illness. Psychological Services. 2006;3(4):262.CrossRef
49.
50.
Rosen A, Proctor EK. Distinctions between treatment outcomes and their implications for treatment evaluation. J Consulting Clinical Psychology. 1981;49(3):418.CrossRefPubMed
51.
Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 2nd ed. Thousand Oaks: Sage Publications, Inc; 2011. p. xviii. 275.
52.
Creswell JW, et al. Best practices for mixed methods research in the health sciences. Bethesda: National Institutes of Health; 2011. p. 10.
53.
Sandelowski M, Voils CI, Knafl G. On quantitizing. J Mixed Methods Res. 2009;3(3):208–22.CrossRef
54.
Carroll KM, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Dependence. 2006;81(3):301–12.CrossRefPubMed
55.
Baekeland F, Lundwall L. Dropping out of treatment: a critical review. Psychological Bull. 1975;82(5):738.CrossRef
56.
O’Brien A, Fahmy R, Singh SP. Disengagement from mental health services. Soc Psychiatry Psychiatric Epidemiology. 2009;44(7):558–68.CrossRef
57.
Wise EA. Evidence-based effectiveness of a private practice intensive outpatient program with dual diagnosis patients. J Dual Diagnosis. 2010;6(1):25–45.CrossRef
58.
Kraemer HC, et al. Caution regarding the use of pilot studies to guide power calculations for study proposals. Archives Gen Psychiatry. 2006;63(5):484–9.CrossRef
59.
Miller J, Schwarz W. Aggregate and individual replication probability within an explicit model of the research process. Psychological Methods. 2011;16(3):337.CrossRefPubMed
60.
Van Dorn RA, et al. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services. J Clinical Psychiatry. 2011;72(4):502–8.CrossRef
61.
Swanson JW, et al. A national study of violent behavior in persons with schizophrenia. Archives General Psychiatry. 2006;63(5):490–9.CrossRef
62.
Swanson JW, et al. Alternative pathways to violence in persons with schizophrenia: the role of childhood antisocial behavior problems. Law Human Behav. 2008;32(3):228–40.CrossRef
63.
Swanson JW, et al. Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. Br J Psychiatry. 2008;193(1):37–43.CrossRefPubMedPubMedCentral
64.
Ball SA. Personality traits, problems, and disorders: clinical applications to substance use disorders. J Res Personality. 2005;39(1):84–102.CrossRef
65.
Proctor EK, et al. Writing implementation research grant proposals: ten key ingredients. Implement Sci. 2012;7(1):1.CrossRef
66.
Faul F, et al. G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.CrossRefPubMed
67.
Swartz MS, et al. Assessing outcomes for consumers in New York's assisted outpatient treatment program. Psychiatric Services. 2010;61(10):976–81.CrossRefPubMed
68.
Gilbert AR, et al. Reductions in arrest under assisted outpatient treatment in New York. Psychiatric Services. 2010;61(10):996–9.CrossRefPubMed
69.
Van Dorn RA, et al. Continuing medication and hospitalization outcomes after assisted outpatient treatment in New York. Psychiatric Services. 2010;61(10):982–7.CrossRefPubMed
70.
Desmarais SL, et al. Characteristics of START assessments completed in mental health jail diversion programs. Behav Sci Law. 2012;30(4):448–69.CrossRefPubMed
71.
Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10(3):799–812.CrossRef
72.
Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries. J Clin Epidemiol. 1998;51(11):1171–8.CrossRefPubMed
73.
McHorney CA, Ware Jr JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993:247–263.
74.
Blazer D, George LK, Landerman R, Pennybacker M, Melville M, Woodbury M, Manton KG, Jordan K. Psychiatric Disorders. Arch Gen Psychiatry. 1985;42(7):651–56.CrossRefPubMed
75.
Patrick CJ, Fowles DC, Krueger RF. Triarchic conceptualization of psychopathy: Developmental origins of disinhibition, boldness, and meanness. Dev Psychopathol. 2009;21(03):913–38.CrossRefPubMed
76.
Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome. Schizophr Bull. 1984;10(3):388–98.CrossRefPubMed
77.
Swartz MS, Swanson JW, Van Dorn RA, Elbogen EB, Shumway M. Patient Preferences for Psychiatric Advance Directives. Int J Forensic Ment Health. 2006;5(1):67–81.CrossRef
78.
Swartz MS, Swanson JW, Wagner HR, Hannon MJ, Burns BJ, Shumway M. Assessment of four stakeholder groups’ preferences concerning outpatient commitment for persons with schizophrenia. Am J Psychiatry. 2003;160:1139–46.CrossRefPubMed
Metadata
Title
Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial
Authors
Richard A. Van Dorn
Sarah L. Desmarais
Candalyn B. Rade
Elizabeth N. Burris
Gary S. Cuddeback
Kiersten L. Johnson
Stephen J. Tueller
Megan L. Comfort
Kim T. Mueser
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-2088-z

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue

Study protocol

App-based serious gaming for training of chest tube insertion: study protocol for a randomized controlled trial

Study protocol

Tight intra-operative blood pressure control versus standard care for patients undergoing hip fracture repair – Hip Fracture Intervention Study for Prevention of Hypotension (HIP-HOP) trial: study protocol for a randomised controlled trial

Study protocol

Differentiated resistance training of the paravertebral muscles in patients with unstable spinal bone metastasis under concomitant radiotherapy: study protocol for a randomized pilot trial

Study protocol

Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trial

Letter

The COMET Initiative database: progress and activities update (2015)

Study protocol

Efficacy of orally administered prednisolone versus partial endodontic treatment on pain reduction in emergency care of acute irreversible pulpitis of mandibular molars: study protocol for a randomized controlled trial